NCT05866497

Brief Summary

Studies were found that a significant relationship between the severe periodontitis and increased CAVI values. While the exact mechanisms linking periodontitis, type 2 diabetes, and cardiovascular disease are not yet fully understood, it is clear that these diseases are interconnected. There are limited data in the literature evaluating the risk of atherosclerosis in diabetic individuals with periodontal disease. In our survey, we hypothesised that severe periodontitis may be a risk factor for the development of subclinical atherosclerosis among people with type 2 diabetes. Thus, we aimed to investigate the potential risk of subclinical atherosclerosis by using a new surrogate marker CAVI in severe periodontitis patients with short-term diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 19, 2023

Completed
Last Updated

May 19, 2023

Status Verified

May 1, 2023

Enrollment Period

8 months

First QC Date

May 10, 2023

Last Update Submit

May 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • CAVI measurements

    mean CAVI values (m/s) in each study groups

    at baseline

Study Arms (4)

diabetes and periodontitis group (group 1)

35 subjects with type 2 diabetes and severe periodontitis were recruited in group 1. The clinical periodontal parameters taken are as follows: plaque index (PI), gingival index (GI), bleeding on brobing (BOP), probing depth (PD) and clinical attachment level (CAL). The present number of teeth in participants was recorded. Cardio-ankle vascular index (CAVI) was measured

Diagnostic Test: clinical periodontal measurementsDiagnostic Test: CAVI measurements

diabetes and periodontally healthy (group 2)

34 subjects with type 2 diabetes and periodontally healthy were recruited in group 2. The clinical periodontal parameters taken are as follows: plaque index (PI), gingival index (GI), bleeding on brobing (BOP), probing depth (PD) and clinical attachment level (CAL). The present number of teeth in participants was recorded. Cardio-ankle vascular index (CAVI) was measured

Diagnostic Test: clinical periodontal measurementsDiagnostic Test: CAVI measurements

systemically healthy and periodontitis (group 3)

32 systemically healthy subjects with severe periodontitis were recruited in group 3. The clinical periodontal parameters taken are as follows: plaque index (PI), gingival index (GI), bleeding on brobing (BOP), probing depth (PD) and clinical attachment level (CAL). The present number of teeth in participants was recorded. Cardio-ankle vascular index (CAVI) was measured

Diagnostic Test: clinical periodontal measurementsDiagnostic Test: CAVI measurements

systemically healthy and periodontally healthy (group 4)

35 systemically and periodontally healthy subjects were recruited in group 4. The clinical periodontal parameters taken are as follows: plaque index (PI), gingival index (GI), bleeding on brobing (BOP), probing depth (PD) and clinical attachment level (CAL). The present number of teeth in participants was recorded. Cardio-ankle vascular index (CAVI) was measured

Diagnostic Test: clinical periodontal measurementsDiagnostic Test: CAVI measurements

Interventions

Periodontal parameters such as PI, GI, BOP, PD, and CAL were measured using the Williams periodontal probe (Hu-Friedy, Chicago IL). PD and CAL were calculated at six surfaces per tooth, whereas PI and GI were measured at four surfaces per tooth. The periodontal status of patients was determined based on the Classification of Periodontal and Peri-Implant Diseases and Conditions stated in 2017 World Workshop

diabetes and periodontally healthy (group 2)diabetes and periodontitis group (group 1)systemically healthy and periodontally healthy (group 4)systemically healthy and periodontitis (group 3)
CAVI measurementsDIAGNOSTIC_TEST

Arterial stiffness of the participants included in this study were assessed by CAVI index using VaSera (VS-1500N) CAVI device (Fukuda Denshi Co. Ltd., Tokyo, Japan) between both arms and ankles in a supine position. Right and left CAVI values were calculated separately.

diabetes and periodontally healthy (group 2)diabetes and periodontitis group (group 1)systemically healthy and periodontally healthy (group 4)systemically healthy and periodontitis (group 3)

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Type 2 diabetic subjects were selected from patients diagnosed with type 2 diabetes for less than 5 years recruited from those patients attending to the outpatient clinic at the Department of Endocrinology at Pamukkale University Hospital. Systemically healthy subjects were recruited from the patients who referred to Faculty of Dentistry in Pamukkale University for dental treatments. Medical conditions of systemically healthy subjects were determined with detailed systemic examinations and biochemical analyses were performed in the Department of Endocrinology at Pamukkale University Hospital. Patients with severe periodontitis or periodontally healthy subjects were selected from the patients who referred to the Periodontology Clinic in Faculty of Dentistry at Pamukkale University for periodontal examinations.

You may qualify if:

  • short-term type 2 diabetes mellitus diagnosis (\<5 years) or systemically healthy subjects
  • patients with severe periodontitis or periodontally healthy subjects

You may not qualify if:

  • had vascular diabetic complications
  • hypertensive and dyslipidaemic/hyperlipidaemic patients
  • Smokers and ex-smokers
  • pregnancy and lactation
  • using systemic antibiotic or anti-inflammatory drugs in the 6 months before the start of the study
  • history of past periodontal treatment within 6 months period
  • ankle-branchial index (ABI) values less than 0.9
  • obesity with BMI ≥ 30 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University Faculty of Dentistry

Denizli, 20160, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronary DiseaseDiabetes Mellitus, Type 2Periodontitis

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Gizem Torumtay Cin, PhD

    Pamukkale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

May 10, 2023

First Posted

May 19, 2023

Study Start

June 10, 2022

Primary Completion

January 21, 2023

Study Completion

January 21, 2023

Last Updated

May 19, 2023

Record last verified: 2023-05

Locations